Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
Cancer Research
|
August 7, 2019
SNAI1 Promotes the Cholangiocellular Phenotype, but not Epithelial-Mesenchymal Transition, in a Murine Hepatocellular Carcinoma Model
Meng Xu, Jingxiao Wang, Zhong Xu, et al.
Cells
|
April 13, 2026
Urinary Exosomal miRNAs as Non-Invasive Biomarkers Linked to Podocyte Morphometry in CKD
Tim Lange, Luzia Maron, Stefan Simm, et al.
Hepatology (Baltimore, Md.)
|
December 28, 2020
Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans
Haichuan Wang, Xinhua Song, Haotian Liao, et al.
Oncotarget
|
December 7, 2017
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis
Antonio Cigliano, Maria G Pilo, Lei Li, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 6, 2024
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma
Antonio Cigliano, Isabella Gigante, Marina Serra, et al.
Gut
|
September 12, 2021
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer
Steffie Revia, Agnieszka Seretny, Lena Wendler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2018
Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma
Xinhua Song, Xianqiong Liu, Haichuan Wang, et al.
Molecular & Cellular Proteomics : MCP
|
July 23, 2025
Accurate MS-Based Diagnostic Amyloid Typing Using Endogenously Normalized Protein Intensities in Formalin-Fixed Paraffin-Embedded Tissue
Vanessa Hollfoth, Arslan Ali, Eyyub Bag, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 16, 2023
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
Antonio Cigliano, Shanshan Zhang, Silvia Ribback, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 2, 2022
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
Antonio Cigliano, Shanshan Zhang, Silvia Ribback, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
Cancer Research
|
August 7, 2019
SNAI1 Promotes the Cholangiocellular Phenotype, but not Epithelial-Mesenchymal Transition, in a Murine Hepatocellular Carcinoma Model
Meng Xu, Jingxiao Wang, Zhong Xu, et al.
Cells
|
April 13, 2026
Urinary Exosomal miRNAs as Non-Invasive Biomarkers Linked to Podocyte Morphometry in CKD
Tim Lange, Luzia Maron, Stefan Simm, et al.
Hepatology (Baltimore, Md.)
|
December 28, 2020
Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans
Haichuan Wang, Xinhua Song, Haotian Liao, et al.
Oncotarget
|
December 7, 2017
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis
Antonio Cigliano, Maria G Pilo, Lei Li, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 6, 2024
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma
Antonio Cigliano, Isabella Gigante, Marina Serra, et al.
Gut
|
September 12, 2021
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer
Steffie Revia, Agnieszka Seretny, Lena Wendler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2018
Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma
Xinhua Song, Xianqiong Liu, Haichuan Wang, et al.
Molecular & Cellular Proteomics : MCP
|
July 23, 2025
Accurate MS-Based Diagnostic Amyloid Typing Using Endogenously Normalized Protein Intensities in Formalin-Fixed Paraffin-Embedded Tissue
Vanessa Hollfoth, Arslan Ali, Eyyub Bag, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 16, 2023
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
Antonio Cigliano, Shanshan Zhang, Silvia Ribback, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 2, 2022
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
Antonio Cigliano, Shanshan Zhang, Silvia Ribback, et al.
Page
of 10